NOVAST LABS FDA Approval ANDA 206490

ANDA 206490

NOVAST LABS

FDA Drug Application

Application #206490

Application Sponsors

ANDA 206490NOVAST LABS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL5MG0NORETHINDRONE ACETATENORETHINDRONE ACETATE

FDA Submissions

UNKNOWN; ORIG1AP2018-11-05STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206490
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"NORETHINDRONE ACETATE","activeIngredients":"NORETHINDRONE ACETATE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/05\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-11-05
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.